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A recent paper in Kidney International on the French experi-
ence with COVID-19 in dialysis patients states that between 
March 16 and May 4, 2020, of the 1621 infected patients 
listed in the REIN registry, 344 patients died, a confirma-
tion of the high death toll among dialysis patients during the 
COVID-19 epidemic [1].
In this nationwide report, the prevalence of patients with 
COVID-19 varied between regions from less than 1% to 
over 10%. The incidence of the disease was higher in males, 
and in patients with diabetes and other comorbidities, while 
being on dialysis at home was associated with a lower rate of 
infection. In fact, during the SARS-CoV-2 pandemic, numer-
ous studies showed that end-stage kidney disease (ESKD) is 
a major risk factor for developing severe COVID-19 [2, 3].
Acknowledging this grim prognosis has been a stimu-
lus for reconsidering dialysis policy from a different point 
of view [1, 3, 4]. Home dialysis has been advocated as a 
safer option in times of epidemic and, among others, the 
French health care authorities strongly supported the devel-
opment of home-based techniques in their documents which 
appeared in response to the COVID-19 epidemic [5, 6]. 
Potential drawbacks were also underlined, as were patients’ 
need to have frequent contacts with a dialysis center and to 
avoid being isolated.
Home hemodialysis is still a Cinderella in Europe: while 
daily hemodialysis is considered to be one of the best renal 
replacement treatments, combining higher survival and a 
good quality of life, its penetration is limited. In France this 
technique has undergone a relatively rapid diffusion in the 
last 5 years. According to the data from the French Bio-
medicine Agency, during the peak period of the epidemic, 
between March 1 and June 15, 2020, only 7 of the 423 
patients on home hemodialysis in France were diagnosed 
with COVID-19; the incidence is similar to that observed in 
patients treated with peritoneal dialysis (1.8%). Even con-
sidering the different distribution of home dialysis in France 
(Fig. 1), the recorded incidence is significantly lower than 
that observed in patients on in-center hemodialysis (1856 
COVID out of 48,840 patients, 3.8%; p = 0.02) [7]. Inter-
estingly, the virus diffusion was the highest in the regions 
with the highest prevalence of home hemodialysis, and the 
favorable effect was more evident in settings with high virus 
circulation. For instance, in the Ile de France region, one of 
the most affected by the pandemic, data from the Biomedi-
cine Agency indicate that 930 out of 8,025 patients (11.5%) 
on in-center hemodialysis were diagnosed with COVID-19, 
whereas only 4 out of 109 patients on home hemodialy-
sis developed the disease (3.6%) (p = 0.001). Presumably 
because of the lower age (mean 54 years ± 14 years) and 
comorbidity burden, none of the patients on home hemodi-
alysis died. Furthermore, while home dialysis encompasses 
7% of all French dialysis patients, data from the French Bio-
medicine Agency show that the proportion of home dialysis 
patients (whether on hemodialysis or on peritoneal dialysis) 
represented 2.6% of the total number of dialysis patients 
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diagnosed with COVID-19 during the period March–Octo-
ber 2020 [64 out of 2437patients]; this proportion would 
appear to remain stable during the second epidemic wave.
The organization of a home hemodialysis network is not 
simple. In our network of care (based upon cooperation 
between the Tenon Hospital and the AURA Association) 
we are presently following 55 home hemodialysis patients, 
in a setting (Paris) that had a high virus circulation.
In our dialysis network, in normal conditions, outside of 
the epidemic, half of the patients who are trained for home 
hemodialysis are referred by our center and the other half 
by other centers. They are first evaluated by a nephrolo-
gist and a nursing team during a consultation in which our 
training policy is explained, and the advantages as well 
as the constraints of home treatment are set forth. The 
training period usually lasts eight weeks, during which the 
patients learn the management of dialysis and get accus-
tomed to self-needling using the button-hole method. 
Training includes how to set up the generator, the manage-
ment of alarms and how to adapt their dry weight. Nurses 
evaluate the patient’s home and discuss how to solve possi-
ble issues (such as storage or waste management). The first 
dialysis session which is performed at home is organized 
in the presence of a nurse and a nephrologist. The dispos-
ables are sent once or twice a month to the patient’s home 
by a non-profit association with experience in managing 
home hemodialysis in France (AURA for the Ile de France 
region), and waste retrieval is carried out weekly by a pri-
vate company.
Each month one dialysis session is organized in the train-
ing center, thus providing an opportunity for blood tests to 
be done, as well as for clinical evaluation and discussion of 
any problems that may have occurred during the period. Our 
training unit is located on the same floor as the hemodialysis 
unit, but is separated from the main unit, with dedicated 
waiting rooms. The nursing team is entirely dedicated to 
supervising home hemodialysis.
During the COVID-19 epidemic, the dialysis network 
needed to be adapted, balancing the need for closely moni-
toring the fragile patients’ clinical condition, with the need 
to minimize their exposure to the hospital [4]. Providing 
home assistance by a trained nurse, as is routinely done 
in peritoneal dialysis, was not proposed, as in France this 
option is not allowed for home hemodialysis. Training for 
home hemodialysis was performed on an intensified daily 
basis, balancing the risks of frequent hospital visits with 
the advantage of receiving treatment in a safer setting. The 
risks of social isolation were kept in mind, and a policy of 
distant monitoring was established on a case-by-case basis. 
We were able to train eight patients during the first phase 
of the epidemic and to secure them on home hemodialysis.
The delivery of consumables for hemodialysis was car-
ried out respecting the barrier measures. Access to inter-
ventional radiology for the management of vascular access 
complications remained operational in our region during the 
period of the study. The creation of a new vascular access 
was however limited to emergencies.
We also chose to maintain the regular dialysis sessions 
and controls in the training unit, but we increased the inter-
vals between visits from the usual monthly frequency to 
once every 6–8 weeks, adapting the control schedule to 
each patient’s circumstances. Conversely, patients who had 
technical problems or experienced vascular access difficul-
ties were immediately referred to the training center to try 
to promptly solve the problems. We considered that in such 
cases direct interaction played an important role in reassur-
ing patients, and this advantage was balanced against their 
exposure to a hospital setting, with an increased risk of con-
tamination. The longer intervals between visits were com-
pensated by regular phone contacts, in order to strengthen 
monitoring, to reassure our patients and to remind them 
of the importance of respecting the barrier measures and 
employing personal protective equipment whenever they 
were outside their homes.
Of our 55 patients, 15 presented symptoms consistent 
with a viral infection. They all underwent a SARS-CoV-2 
PCR. Two tested positive, 13 negative. Furthermore, glob-
ally 52 of our 55 patients later agreed to have a SARS-CoV-2 
serology test performed, which was positive in the 2 patients 
Fig. 1  Percentage of home dialysis for all dialysis patients in France 
as of December 31, 2018. The numbers in the enlarged figure indicate 
administrative department
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who had previously tested positive to SARS-CoV-2 and neg-
ative in the remaining 50 patients.
Therefore, within the limits of a small series, and while 
waiting for additional data, we would like to confirm that 
our experience underlines the importance of developing an 
efficient home hemodialysis network, able to patients in a 
time of epidemic.
The catastrophic COVID-19 pandemic will presumably 
not be the last one in our globalized world. Home hemodi-
alysis allows effective containment, and this effect is particu-
larly high in endemic areas, potentially reducing mortality 
in dialysis patients. This consideration should further sup-
port the development of home hemodialysis, overcoming 
the many barriers to its development. Performing home 
hemodialysis, however, involves more than merely moving 
the dialysis machine from hospital to home. Developing a 
home hemodialysis network is a complex and demanding 
task, and in many European countries reimbursement fails 
to fully cover the costs, in particular if patients are closely 
monitored.
In France, for example, the average cost of a home dialy-
sis session was estimated at € 221.78, while the flat reim-
bursement rate for home hemodialysis is only € 225.15. The 
lack of profit in home dialysis is a disincentive to its growth, 
despite its benefits for quality of life and, possibly, survival 
[8]. In addition to this problem, there are significant dis-
parities in access to home dialysis among regions, mainly 
reflecting the involvement of each region’s nephrology team. 
A lack of training of nephrologists and lack of information 
for patients are further important barriers to the development 
of home hemodialysis.
The present report, therefore, is a call for dedicated 
investment in home hemodialysis, and for an unbiased 
appraisal of its complexity, to implement the old, but always 
valuable concept of “home dialysis first” for patients who 
cannot receive a preemptive kidney transplantation [9].
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